Glen Eagle Advisors, LLC Abiomed Inc Transaction History

Glen Eagle Advisors, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	N/A	-200 Closed	0 $0
Q4 2022 Aug 13, 2024	SELL	$0.0 - $381.3 $0 - $64,821	-170 Closed	0 $0
Q1 2022 Aug 13, 2024	SELL	$277.25 - $366.29 $8,317 - $10,988	-30 Reduced 15.0%	170 $56.3 Million
Q4 2020 Aug 13, 2024	BUY	$251.88 - $324.2 $50,376 - $64,840	200 New	200 $64.8 Million
Q1 2019 Aug 13, 2024	BUY	$276.39 - $362.25 $55,278 - $72,450	200 New	200 $57.1 Million
Q2 2018 Aug 13, 2024	SELL	$278.07 - $446.21 $16.1 Million - $25.9 Million	-57,998 Reduced 99.66%	200 $81.8 Million
Q1 2018 Aug 14, 2024	BUY	$192.49 - $295.85 $38,498 - $59,170	200 New	200 $58.2 Million
Q1 2018 Aug 13, 2024	BUY	$192.49 - $295.85 $11.2 Million - $17.2 Million	58,198 New	58,198 $58.2 Million
Q4 2017 Aug 13, 2024	SELL	$168.78 - $199.74 $33,756 - $39,948	-200 Closed	0 $0
Q3 2017 Aug 13, 2024	BUY	$145.39 - $168.6 $29,077 - $33,720	200	200 $33.7 Million

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Glen Eagle Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Glen Eagle Advisors, LLC with notifications on news.